TY - JOUR
T1 - DNA methylation-based reclassification of olfactory neuroblastoma
AU - Capper, David
AU - Engel, Nils W.
AU - Stichel, Damian
AU - Lechner, Matt
AU - Glöss, Stefanie
AU - Schmid, Simone
AU - Koelsche, Christian
AU - Schrimpf, Daniel
AU - Niesen, Judith
AU - Wefers, Annika K.
AU - Jones, David T.W.
AU - Sill, Martin
AU - Weigert, Oliver
AU - Ligon, Keith L.
AU - Olar, Adriana
AU - Koch, Arend
AU - Forster, Martin
AU - Moran, Sebastian
AU - Tirado, Oscar M.
AU - Sáinz-Jaspeado, Miguel
AU - Mora, Jaume
AU - Esteller, Manel
AU - Alonso, Javier
AU - del Muro, Xavier Garcia
AU - Paulus, Werner
AU - Felsberg, Jörg
AU - Reifenberger, Guido
AU - Glatzel, Markus
AU - Frank, Stephan
AU - Monoranu, Camelia M.
AU - Lund, Valerie J.
AU - von Deimling, Andreas
AU - Pfister, Stefan
AU - Buslei, Rolf
AU - Ribbat-Idel, Julika
AU - Perner, Sven
AU - Gudziol, Volker
AU - Meinhardt, Matthias
AU - Schüller, Ulrich
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Olfactory neuroblastoma/esthesioneuroblastoma (ONB) is an uncommon neuroectodermal neoplasm thought to arise from the olfactory epithelium. Little is known about its molecular pathogenesis. For this study, a retrospective cohort of n = 66 tumor samples with the institutional diagnosis of ONB was analyzed by immunohistochemistry, genome-wide DNA methylation profiling, copy number analysis, and in a subset, next-generation panel sequencing of 560 tumor-associated genes. DNA methylation profiles were compared to those of relevant differential diagnoses of ONB. Unsupervised hierarchical clustering analysis of DNA methylation data revealed four subgroups among institutionally diagnosed ONB. The largest group (n = 42, 64%, Core ONB) presented with classical ONB histology and no overlap with other classes upon methylation profiling-based t-distributed stochastic neighbor embedding (t-SNE) analysis. A second DNA methylation group (n = 7, 11%) with CpG island methylator phenotype (CIMP) consisted of cases with strong expression of cytokeratin, no or scarce chromogranin A expression and IDH2 hotspot mutation in all cases. T-SNE analysis clustered these cases together with sinonasal carcinoma with IDH2 mutation. Four cases (6%) formed a small group characterized by an overall high level of DNA methylation, but without CIMP. The fourth group consisted of 13 cases that had heterogeneous DNA methylation profiles and strong cytokeratin expression in most cases. In t-SNE analysis, these cases mostly grouped among sinonasal adenocarcinoma, squamous cell carcinoma, and undifferentiated carcinoma. Copy number analysis indicated highly recurrent chromosomal changes among Core ONB with a high frequency of combined loss of chromosome 1–4, 8–10, and 12. NGS sequencing did not reveal highly recurrent mutations in ONB, with the only recurrently mutated genes being TP53 and DNMT3A. In conclusion, we demonstrate that institutionally diagnosed ONB are a heterogeneous group of tumors. Expression of cytokeratin, chromogranin A, the mutational status of IDH2 as well as DNA methylation patterns may greatly aid in the precise classification of ONB.
AB - Olfactory neuroblastoma/esthesioneuroblastoma (ONB) is an uncommon neuroectodermal neoplasm thought to arise from the olfactory epithelium. Little is known about its molecular pathogenesis. For this study, a retrospective cohort of n = 66 tumor samples with the institutional diagnosis of ONB was analyzed by immunohistochemistry, genome-wide DNA methylation profiling, copy number analysis, and in a subset, next-generation panel sequencing of 560 tumor-associated genes. DNA methylation profiles were compared to those of relevant differential diagnoses of ONB. Unsupervised hierarchical clustering analysis of DNA methylation data revealed four subgroups among institutionally diagnosed ONB. The largest group (n = 42, 64%, Core ONB) presented with classical ONB histology and no overlap with other classes upon methylation profiling-based t-distributed stochastic neighbor embedding (t-SNE) analysis. A second DNA methylation group (n = 7, 11%) with CpG island methylator phenotype (CIMP) consisted of cases with strong expression of cytokeratin, no or scarce chromogranin A expression and IDH2 hotspot mutation in all cases. T-SNE analysis clustered these cases together with sinonasal carcinoma with IDH2 mutation. Four cases (6%) formed a small group characterized by an overall high level of DNA methylation, but without CIMP. The fourth group consisted of 13 cases that had heterogeneous DNA methylation profiles and strong cytokeratin expression in most cases. In t-SNE analysis, these cases mostly grouped among sinonasal adenocarcinoma, squamous cell carcinoma, and undifferentiated carcinoma. Copy number analysis indicated highly recurrent chromosomal changes among Core ONB with a high frequency of combined loss of chromosome 1–4, 8–10, and 12. NGS sequencing did not reveal highly recurrent mutations in ONB, with the only recurrently mutated genes being TP53 and DNMT3A. In conclusion, we demonstrate that institutionally diagnosed ONB are a heterogeneous group of tumors. Expression of cytokeratin, chromogranin A, the mutational status of IDH2 as well as DNA methylation patterns may greatly aid in the precise classification of ONB.
UR - http://www.scopus.com/inward/record.url?scp=85046440199&partnerID=8YFLogxK
U2 - 10.1007/s00401-018-1854-7
DO - 10.1007/s00401-018-1854-7
M3 - Journal articles
C2 - 29730775
AN - SCOPUS:85046440199
SN - 0001-6322
VL - 136
SP - 255
EP - 271
JO - Acta Neuropathologica
JF - Acta Neuropathologica
IS - 2
ER -